Ascendis Health Directors’ Associates Make Strategic Share Acquisitions in On-Market Deals

  • Associates of Ascendis Health directors, Carl Neethling and Theunis de Bruyn, acquire shares in on-market transactions.
  • Carl Neethling's associate, ACN Capital (Pty) Ltd, purchased 192,854 ordinary shares, while Theunis de Bruyn's associate, Calibre Investment Holdings (Pty) Ltd, acquired the same amount.
  • The transactions were made at a price of 61.37 cents per security, with a total value of R118,354.50 each.

Ascendis Health Limited saw associates of two of its directors, Carl Neethling and Theunis de Bruyn, engage in on-market transactions to acquire shares. The dealings were conducted in accordance with the JSE Limited Listings Requirements.

On 23 June 2023, Carl Neethling, a director of Ascendis Health Limited, purchased 192,854 ordinary shares at a price of 61.37 cents per security, amounting to a total value of R118,354.50. This transaction was carried out through Neethling’s associate, ACN Capital (Pty) Ltd. Neethling has an indirect, beneficial interest in the purchase, as he is the ultimate controlling shareholder of ACN Capital (Pty) Ltd.

Simultaneously, Theunis de Bruyn, also a director of Ascendis Health Limited, acquired 192,854 ordinary shares at the same price of 61.37 cents per security, totaling R118,354.50. De Bruyn’s purchase was made through his associate, Calibre Investment Holdings (Pty) Ltd. He holds an indirect, beneficial interest in the transaction due to his position as a director and shareholder of Calibre Investment Holdings (Pty) Ltd.

The acquisitions by the directors’ associates were granted clearance in accordance with paragraph 3.66 of the JSE Limited Listings Requirements.

Ascendis Health Limited is a highly regarded healthcare company operating in South Africa, offering a comprehensive range of healthcare products and services, including pharmaceuticals, consumer health goods, and medical devices. The recent share acquisitions by the associates of the directors exemplify their confidence in Ascendis Health’s future prospects and investment potential.

The management of Ascendis Health believes that these transactions further align the interests of the directors and their associates with the company’s success. By increasing their indirect beneficial ownership, the directors and their associates demonstrate their commitment to Ascendis Health’s long-term growth strategy.

Related

Rateweb

South Africa’s primary source of financial tools and information

Contact Us

admin@rateweb.co.za

Disclaimer

Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.